IN2015DN03962A - - Google Patents

Download PDF

Info

Publication number
IN2015DN03962A
IN2015DN03962A IN3962DEN2015A IN2015DN03962A IN 2015DN03962 A IN2015DN03962 A IN 2015DN03962A IN 3962DEN2015 A IN3962DEN2015 A IN 3962DEN2015A IN 2015DN03962 A IN2015DN03962 A IN 2015DN03962A
Authority
IN
India
Prior art keywords
mycobacterium
proteins
esx
secreted
tuberculosis
Prior art date
Application number
Other languages
English (en)
Inventor
Claus Aagaard
Ida Rosenkrands
Truc Thi Kim Thanh Hoang
Peter Andersen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Publication of IN2015DN03962A publication Critical patent/IN2015DN03962A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN3962DEN2015 2012-10-23 2013-10-18 IN2015DN03962A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA201200652 2012-10-23
DKPA201200653 2012-10-23
DKPA201200654 2012-10-23
DKPA201300477 2013-08-23
PCT/DK2013/000070 WO2014063704A2 (en) 2012-10-23 2013-10-18 M. tuberculosis vaccines

Publications (1)

Publication Number Publication Date
IN2015DN03962A true IN2015DN03962A (zh) 2015-10-02

Family

ID=49679267

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3962DEN2015 IN2015DN03962A (zh) 2012-10-23 2013-10-18

Country Status (8)

Country Link
US (1) US9526773B2 (zh)
EP (1) EP2912056B1 (zh)
JP (1) JP6470179B2 (zh)
CN (1) CN104736555B (zh)
BR (1) BR112015009070A2 (zh)
IN (1) IN2015DN03962A (zh)
WO (1) WO2014063704A2 (zh)
ZA (1) ZA201503467B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3092000A1 (en) * 2014-01-09 2016-11-16 Transgene SA Fusion of heterooligomeric mycobacterial antigens
JP2017513860A (ja) * 2014-04-24 2017-06-01 スタテンス セールム インスティトゥート 新規結核菌（ｍ．ｔｕｂｅｒｃｕｌｏｓｉｓ）ワクチン
EP3355917A1 (en) * 2015-09-30 2018-08-08 Boehringer Ingelheim Vetmedica GmbH Improved modular antigen transportation molecules and uses therof in animals
CN105218680B (zh) * 2015-10-21 2019-06-25 中山大学 一种用于诱导外周血单个核细胞产生细胞因子的结核分支杆菌融合蛋白
CN105218681B (zh) * 2015-10-21 2019-06-25 中山大学 一种用于诱导外周血单个核细胞产生结核特异性细胞因子的融合蛋白
CN105567660B (zh) * 2016-01-08 2018-11-20 中国人民解放军第四军医大学 一种大肠杆菌重组表达结核分枝杆菌Rv2837c活性蛋白的方法及其应用
WO2017205225A2 (en) * 2016-05-21 2017-11-30 Infectious Disease Research Institute Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium infections
CN109843321A (zh) 2016-06-22 2019-06-04 国际艾滋病疫苗行动组织公司 作为结核病疫苗的重组巨细胞病毒载体
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
BR112019014147A2 (pt) * 2017-01-09 2020-02-11 Biomunex Pharmaceuticals Ligante polipeptídico para a preparação de anticorpos multiespecíficos
WO2019079155A1 (en) 2017-10-17 2019-04-25 International Aids Vaccine Initiative, Inc. CASSETTES OF ANTIGENS OF TUBERCULOSIS
CN114222762A (zh) * 2019-06-14 2022-03-22 史坦恩斯血清研究所 用于结核疫苗的融合蛋白
WO2021022001A1 (en) * 2019-08-01 2021-02-04 Trustees Of Tufts College Vaccine compositions and methods of selecting antigens
CN110590958B (zh) * 2019-09-11 2021-04-13 中国人民解放军总医院第八医学中心 一种串联多肽及其在抗结核分枝杆菌的免疫保护中的应用
WO2023156676A1 (en) 2022-02-21 2023-08-24 Statens Serum Institut A novel cationic adjuvant composition
CN115184603B (zh) * 2022-06-30 2024-02-06 首都医科大学附属北京胸科医院 EspC蛋白在制备结核分枝杆菌分离或富集产品中的应用
CN118108815B (zh) * 2024-04-23 2024-07-23 成都康华生物制品股份有限公司 结核分枝杆菌多免疫原抗原、编码其的mRNA、应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051748A2 (en) * 1998-04-07 1999-10-14 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
ATE535600T1 (de) 2002-04-05 2011-12-15 Pasteur Institut Identifizierung der virulenz-assoziierten region rd1, die die entwicklung von verbesserten impstoffen mit m. microti ermöglicht
EP2421557B1 (en) 2009-04-24 2018-12-05 Statens Serum Institut A tuberculosis tb vaccine to prevent reactivation
US20130345079A1 (en) * 2010-10-27 2013-12-26 Infectious Disease Research Institute Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity

Also Published As

Publication number Publication date
EP2912056B1 (en) 2020-02-12
EP2912056A2 (en) 2015-09-02
JP2015536309A (ja) 2015-12-21
CN104736555A (zh) 2015-06-24
ZA201503467B (en) 2016-11-30
CN104736555B (zh) 2019-06-21
JP6470179B2 (ja) 2019-02-13
WO2014063704A2 (en) 2014-05-01
WO2014063704A3 (en) 2014-06-19
US9526773B2 (en) 2016-12-27
WO2014063704A8 (en) 2015-07-30
US20150290311A1 (en) 2015-10-15
BR112015009070A2 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
IN2015DN03962A (zh)
BR112016023778A2 (pt) proteína de fusão ou coquetel antígeno, uso de uma proteína de fusão ou coquetel antígeno, vacina, e método para a imunização de um animal, incluindo um ser humano, contra a tuberculose causada por micobactérias virulentas
MX2016009072A (es) Fusion de antigenos micobacterianos heterooligomericos.
EA201990566A1 (ru) Композиции, содержащие бактериальные штаммы
WO2016176624A3 (en) Porcine pestvirus, vaccines, and assays
BR112018070187A8 (pt) receptores quiméricos para flt3 e seus métodos de uso
EA201590184A1 (ru) Вакцина на основе микобактериальных антигенов
PH12015500092A1 (en) Compositions for immunising against staphylococcus aureus
EA201391183A1 (ru) Способы усиления иммуногенспецифических иммунных ответов при помощи векторных вакцин
PH12014502855A1 (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
NZ725212A (en) Group a streptococcus vaccine
EP3491386A4 (en) IMMUNOASSAY METHODS AND COMPOSITIONS FOR DETECTING INFECTIONS USING TESTANTIGENS AS CROSS-REACTIVE CONTROLLING ANTIQUE
NZ702285A (en) Staphylococcal coagulase antigens and methods of their use
WO2015144732A3 (en) Uses of parasite macrophage migration inhibitory factors
MX2019008779A (es) Antigenos de pseudomonas y combinaciones de antigenos.
EA201691091A1 (ru) Диагностические реагенты для улучшенной in vivo или in vitro клеточно-опосредованной иммунологической диагностики туберкулеза
MX2018012270A (es) Novedosas formulaciones de vacuna neumococica.
WO2015184272A3 (en) Expression and conformational analysis of engineered influenza hemagglutinin
WO2014160098A3 (en) Bordetella specific human recombinant antibodies and uses thereof
WO2014036438A3 (en) Live brucellosis vaccines comprising attenuated brucella mutants
IN2014CN00547A (zh)
EA201300380A1 (ru) Рекомбинантная mycobacterium в качестве вакцины для применения у людей
CL2015003616A1 (es) Cepa de piscirickettsia salmonis depositada bajo el numero de registro dms 27338; vacuna que la comprende; uso para prevenir infeccion por p. salmonis; y medio de cultivo para p. salmonis.
MX2015004892A (es) Metodos y composiciones que se relacionan con anticuerpos de receptor anti-il-21.
GB201120634D0 (en) Adjuvant polypeptide